Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44/p42 mitogen-activated protein kinase.
about
Biology of Cholangiocytes: From Bench to BedsideApoptosis of cholangiocytes modulated by thioredoxin of carcinogenic liver fluke.Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanismIL-6 downregulates transcription of NTPDase2 via specific promoter elementsTLR4 promotes Cryptosporidium parvum clearance in a mouse model of biliary cryptosporidiosis.NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)-mediated transcriptional repression of microRNA let-7i following microbial infection.IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitisCholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitisRegulation of cholangiocyte proliferation.Foxa1 and Foxa2 regulate bile duct development in mice.IL-6 activates serum and glucocorticoid kinase via p38alpha mitogen-activated protein kinase pathway.Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangiocytes.High expressions of caveolins on the proliferating bile ductules in primary biliary cirrhosisThiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasisDifficulty with diagnosis of malignant pancreatic neoplasms coexisting with chronic pancreatitisTannic acid inhibits cholangiocyte proliferation after bile duct ligation via a cyclic adenosine 5',3'-monophosphate-dependent pathway.Cholangiocyte N-Ras protein mediates lipopolysaccharide-induced interleukin 6 secretion and proliferation.Hepatic artery and portal vein remodeling in rat liver: vascular response to selective cholangiocyte proliferation.Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction.Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasisTranscriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma.Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.Bile acid interactions with cholangiocytes.Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinomaThe immunobiology of cholangiocytes.Cryptosporidium parvum induces B7-H1 expression in cholangiocytes by down-regulating microRNA-513.A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor.Development of the bile ducts: essentials for the clinical hepatologist.Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related molecules in cultured biliary epithelial cells.Gene-disease associations identify a connectome with shared molecular pathways in human cholangiopathies.Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells.Mechanisms of cholangiocyte responses to injury.Cytokine-responsive induction of SAF-1 activity is mediated by a mitogen-activated protein kinase signaling pathway.Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation.The role of the secretin/secretin receptor axis in inflammatory cholangiocyte communication via extracellular vesicles.Modulation of Stat3 activation by the cytosolic phospholipase A2alpha and cyclooxygenase-2-controlled prostaglandin E2 signaling pathway.Biliary infection may exacerbate biliary cystogenesis through the induction of VEGF in cholangiocytes of the polycystic kidney (PCK) rat
P2860
Q26738866-CBE871E1-25FA-4A2C-AF44-CB454FF1C407Q27330293-5F25F7ED-4790-4B3A-A968-6C64156FAF1FQ28568715-8DDE44A0-C666-4E02-864A-D01F0DDBA418Q28572149-A59708F0-DE81-401D-AA96-28E85D47596FQ30430381-1846AAD3-9A6B-4F75-A1FD-27E10FA24A8CQ33581208-2AE628E1-261F-416E-953D-5C57E36ADDABQ33889122-56FE713C-A5F4-4690-904B-7D5D16E58B22Q34116480-CFCC2792-AE65-4B79-8B38-287FEF133AFFQ34206508-D336B47D-BADC-4382-B487-8174BC928D05Q34229378-DFA8B3F2-8ABC-422A-8B1C-109CAFC7E32DQ34658511-470D3B09-F4F8-4058-B9AC-CFCF0109318EQ34804514-E091640F-F878-4F2E-9B0F-009BB985DFBFQ34881846-36669955-E459-43E1-A8B6-629403C75590Q34882042-99955AAD-F08D-4CFC-B2B8-96518AC90406Q35045465-DF542972-D6A8-41CD-8EF9-9A58003B0912Q35064467-791CC778-85A7-4EDD-BFD8-A6205F09F59AQ35064548-6731CA1A-82E6-4BF4-AE82-7C73E93315FFQ35083886-77EF47BF-5F3C-44FE-8ADD-CC7EFBA327C8Q35182830-E5734BB0-3E34-4E38-BDA6-CD8412F22CF1Q35749261-79FC11F8-5811-4B0E-A1C0-D3F620E55FA6Q35769729-7FF13CB9-0789-41EC-9929-F9A058583FECQ35789321-1F493E81-057D-493A-97D0-C2CCB343CA68Q36279142-9195BCE2-7645-4824-AE76-71F7A4801B9AQ36388792-CC43E55D-7C8A-4C27-8A8E-9B59E466DE61Q36506491-148D009F-D9BC-4D07-BF87-B8383ABB9E01Q37064043-CD14558A-2EA4-449B-9FF5-4CEDB294C85DQ37173742-AB4EE6D2-3403-409A-B774-3DAC7772E516Q37468151-CF170E15-9CA5-4C86-9AB3-89C380B39103Q37691482-3FC47671-7D81-44EC-83D4-5BB7EADA8494Q37975904-A113728D-39C4-4F74-BB85-559B8868F084Q38348067-9AF4A6BD-6620-4255-86A2-CDE40294C25FQ38596985-51E9BCBA-881C-4D24-AF51-979966721ABAQ38725977-C00DE47C-3885-40A4-8E27-FA954F01237BQ38819131-A8ED8C62-5B68-43BD-A396-EDDC03CE6E01Q39397552-226F9609-37D1-438B-AA92-85E707B339CCQ39677539-1C07EB9D-14ED-4338-90C2-5B970E7C49B6Q40032518-E18DF11F-39CE-4828-9416-DE4903BAE62CQ40052358-7255B625-32E1-4E1F-ACB5-FA7582ABBAE2Q40264460-FBA4DC53-4A05-45A4-A6F5-3014E3FEB1BAQ40489060-1584A8CE-1EE1-49FD-91E3-8E856AEEDE45
P2860
Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44/p42 mitogen-activated protein kinase.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Lipopolysaccharide induces cho ...... ogen-activated protein kinase.
@en
type
label
Lipopolysaccharide induces cho ...... ogen-activated protein kinase.
@en
prefLabel
Lipopolysaccharide induces cho ...... ogen-activated protein kinase.
@en
P2093
P356
P1433
P1476
Lipopolysaccharide induces cho ...... ogen-activated protein kinase.
@en
P2093
P304
P356
10.1002/HEP.510290423
P407
P577
1999-04-01T00:00:00Z